Sitemap
Page 1 of 9 : Next
Posts
- Category: AIDS
- Granulomatous Pneumocystis carinii Pneumonia in Three Patients with the Acquired Immune Deficiency Syndrome
- Granulomatous Pneumocystis carinii Pneumonia in Three Patients with the Acquired Immune Deficiency Syndrome: Case 2
- Granulomatous Pneumocystis carinii Pneumonia in Three Patients with the Acquired Immune Deficiency Syndrome: Case Reports
- Granulomatous Pneumocystis carinii Pneumonia in Three Patients with the Acquired Immune Deficiency Syndrome: Conclusion
- Granulomatous Pneumocystis carinii Pneumonia in Three Patients with the Acquired Immune Deficiency Syndrome: Discussion
- Category: Airflow Limitation
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: Conclusion
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: COPD patients
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: Discussion
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: Expression of Results and Statistical Analysis
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: Materials and Methods
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: Measuremen t of REE
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: Outcome
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: Results
- Effect of Regular Use of High-dose Nebulized β2-Agonists on Resting Energy Expenditure, Weight, and Handgrip Strength in Patients With Chronic Airflow Limitation: Subjects and Study Design
- Category: Airflow Obstruction
- Comparison of Outpatient Nebulized vs Metered Dose Inhaler Terbutaline in Chronic Airflow Obstruction
- Comparison of Outpatient Nebulized vs Metered Dose Inhaler Terbutaline in Chronic Airflow Obstruction: Conclusion
- Comparison of Outpatient Nebulized vs Metered Dose Inhaler Terbutaline in Chronic Airflow Obstruction: Discussion
- Comparison of Outpatient Nebulized vs Metered Dose Inhaler Terbutaline in Chronic Airflow Obstruction: Material and Methods
- Comparison of Outpatient Nebulized vs Metered Dose Inhaler Terbutaline in Chronic Airflow Obstruction: Patient Assessments
- Comparison of Outpatient Nebulized vs Metered Dose Inhaler Terbutaline in Chronic Airflow Obstruction: Results
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Conclusion
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Discussion
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Exercise tolerance
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Materials and Methods
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Outcome
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Outcome Measurements
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Rehabilitation Program
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Results
- Physiological Response to Moderate Exercise Workloads in a Pulmonary Rehabilitation Program in Patients With Airflow Obstruction: Statistical Analysis
- Category: Airway
- Pressure Support Compensation and Demand Continuous Positive Airway Pressure
- Pressure Support Compensation and Demand Continuous Positive Airway Pressure: Conclusion
- Pressure Support Compensation and Demand Continuous Positive Airway Pressure: Discussion
- Pressure Support Compensation and Demand Continuous Positive Airway Pressure: Outcome
- Pressure Support Compensation and Demand Continuous Positive Airway Pressure: Pressure Support Compensation for Added Inspiratory Work
- Pressure Support Compensation and Demand Continuous Positive Airway Pressure: Results
- Pressure Support Compensation and Demand Continuous Positive Airway Pressure: Subjects Work and Pressure Support
- Category: Allergy
- Category: Antibiotics
- Category: Antithrombotic Therapy
- Antithrombotic Therapy for Cerebrovascular Disorders
- Antithrombotic Therapy for Cerebrovascular Disorders: Acute Myocardial Infarction
- Antithrombotic Therapy for Cerebrovascular Disorders: Cardiogenic Brain Embolus
- Antithrombotic Therapy for Cerebrovascular Disorders: Completed Stroke
- Antithrombotic Therapy for Cerebrovascular Disorders: Differential Diagnosis of Stroke
- Antithrombotic Therapy for Cerebrovascular Disorders: Echocardiographically
- Antithrombotic Therapy for Cerebrovascular Disorders: Echocardtographic Finding
- Antithrombotic Therapy for Cerebrovascular Disorders: Features of the stroke
- Antithrombotic Therapy for Cerebrovascular Disorders: Hemorrhagic infarction
- Antithrombotic Therapy for Cerebrovascular Disorders: Idiopathic Hypertrophic Subaortic Stenosis
- Antithrombotic Therapy for Cerebrovascular Disorders: Immediate Anticoagulation of Embolic Stroke
- Antithrombotic Therapy for Cerebrovascular Disorders: Infective (Bacterial) Endocarditis
- Antithrombotic Therapy for Cerebrovascular Disorders: Mitral Valve Prolapse
- Antithrombotic Therapy for Cerebrovascular Disorders: Nonembouc Stroke
- Antithrombotic Therapy for Cerebrovascular Disorders: Nonvalvular Atrial Fibrillation
- Antithrombotic Therapy for Cerebrovascular Disorders: Paradoxic Embolism and Congenital Heart Disease
- Antithrombotic Therapy for Cerebrovascular Disorders: Platelet Antiaggregation Agents
- Antithrombotic Therapy for Cerebrovascular Disorders: Primary Stroke Prevention
- Antithrombotic Therapy for Cerebrovascular Disorders: Progressing Thrombotic Strokes
- Antithrombotic Therapy for Cerebrovascular Disorders: Sick Sinus Syndrome
- Antithrombotic Therapy for Cerebrovascular Disorders: Summary and Recommendations
- Antithrombotic Therapy for Cerebrovascular Disorders: Valvular Heart Disease
- Antithrombotic Therapy for Cerebrovascular Disorders: Ventricular Aneurysm
- Category: Asthma
- A Survey of Asthma Care in Managed Care Organizations
- A Survey of Asthma Care in Managed Care Organizations: Characteristics of Asthma-Specific Quality Improvement Activities
- A Survey of Asthma Care in Managed Care Organizations: Conclusions
- A Survey of Asthma Care in Managed Care Organizations: Discussion
- A Survey of Asthma Care in Managed Care Organizations: Materials and Methods
- A Survey of Asthma Care in Managed Care Organizations: Results
- A Survey of Asthma Care in Managed Care Organizations: Statistical Analysis
- Comparison of the Effects of Nebulized Terbutaline with Intravenous Enprofylline in Patients with Acute Asthma
- Comparison of the Effects of Nebulized Terbutaline with Intravenous Enprofylline in Patients with Acute Asthma: Materials and Methods
- Psychobiological Aspects of Asthma and the Consequent Research Implications
- Psychobiological Aspects of Asthma and the Consequent Research Implications: THE INTERACTION OF MEDICAL
- Psychobiological Aspects of Asthma and the Consequent Research Implications: THE INTERACTION OF MEDICAL part 2
- Psychobiological Aspects of Asthma and the Consequent Research Implications: THE INTERACTION OF MEDICAL part 3
- Psychobiological Aspects of Asthma and the Consequent Research Implications: THE INTERACTION OF MEDICAL part 4
- Psychobiological Aspects of Asthma and the Consequent Research Implications: THE INTERACTION OF MEDICAL part 5
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma: Conclusion
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma: Diagnosed patients
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma: Discharge from hospital
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma: Discussion
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma: NMAD patients
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma: Outcome
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma: Patients and Methods
- Psychological Defenses and Coping Styles in Patients Following a Life-Threatening Attack of Asthma: Results
- Category: Asthma inhalers
- Category: Benzodiazepines
- Prospective assessment of pregnancy outcome following first trimester exposure to benzodiazepines
- Prospective assessment of pregnancy outcome: DISCUSSION
- Prospective assessment of pregnancy outcome: PATIENTS AND METHODS
- Prospective assessment of pregnancy outcome: RESULTS(1)
- Prospective assessment of pregnancy outcome: RESULTS(2)
- Category: Blood Pressure
- Category: Breathe with Symbicort
- Category: Bronchus Avulsion
- Category: Canadian Health&Care Mall
- Category: Cancer
- Acrokeratosis Paraneoplastica with Adenocarcinoma of the Colon Treated with Topical Tretinoin
- Acrokeratosis Paraneoplastica with Adenocarcinoma of the Colon Treated with Topical Tretinoin: CASE REPORT
- Acrokeratosis Paraneoplastica with Adenocarcinoma of the Colon Treated with Topical Tretinoin: DISCUSSION
- ADDRESSING MULTIPLE BREAST CANCER RISK: Discussion
- ADDRESSING MULTIPLE BREAST CANCER RISK: METHODS
- ADDRESSING MULTIPLE BREAST CANCER RISK: METHODS part 2
- ADDRESSING MULTIPLE BREAST CANCER RISK: PURPOSE
- ADDRESSING MULTIPLE BREAST CANCER RISK: RESULTS
- American Society of Clinical Oncology
- American Society of Clinical Oncology: Chemotherapy and Radiation Therapy in Glioblastoma Multiforme
- DOXORUBICIN CARDIOTOXICITY IN AFRICAN AMERICANS
- DOXORUBICIN CARDIOTOXICITY IN AFRICAN AMERICANS
- DOXORUBICIN CARDIOTOXICITY IN AFRICAN AMERICANS: PATIENTS AND METHODS
- DOXORUBICIN CARDIOTOXICITY IN AFRICAN AMERICANS: RESULTS
- Implications for Reducing Prostate Cancer Disparities
- Implications for Reducing Prostate Cancer Disparities: DISCUSSION
- Implications for Reducing Prostate Cancer Disparities: PROCEDURES
- Implications for Reducing Prostate Cancer Disparities: RESULTS
- Invasive Squamous Cell Carcinoma of the Oral Mucosa Associated with HPV Type 53
- Invasive Squamous Cell Carcinoma of the Oral Mucosa Associated with HPV Type 53: DISCUSSION
- Specialized Pharmacy Oncology Technician
- Specialized Pharmacy Oncology Technician: DEVELOPMENT OF TECHNICIAN'S ROLE
- Specialized Pharmacy Oncology Technician: DISCUSSION
- Specialized Pharmacy Oncology Technician: EVALUATION OF THE SPOT
- Specialized Pharmacy Oncology Technician: FUNCTIONS ASSIGNED TO SPOT
- Category: Carcinoma
- Category: Cardiology
- Cardiac alphai-adrenergic receptor stimulation: Positive inotropism and arrhythmias (part 1)
- Cardiac alphai-adrenergic receptor stimulation: Positive inotropism and arrhythmias (part 10). CHRONOTROPIC AND ARRHYTHMOGENIC EFFECTS
- Cardiac alphai-adrenergic receptor stimulation: Positive inotropism and arrhythmias (part 11). CONCLUSIONS
- Cardiac alphai-adrenergic receptor stimulation: Positive inotropism and arrhythmias (part 12). CONCLUSIONS
- Cardiac alphai-adrenergic receptor stimulation: Positive inotropism and arrhythmias (part 2)
- Cardiac alphai-adrenergic receptor stimulation: Positive inotropism and arrhythmias (part 3). INOTROPIC EFFECTS
Plugin by dagondesign.com